Jeff Yordon

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.

American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL.